safinamide tablets
for oral use Initial U.S. Approval: 2017

XADAGO is a monoamine oxidase type B (MAO-B) inhibitor indicated as adjunctive treatment to levodopa/carbidopa in patients with Parkinson’s disease (PD) experiencing “off” episodes

Facts about safinamide tablets

Approval Date:  2017
Proprietary Name:  XADAGO (safinamide) tablets
Active Ingredient(s):  safinamide
FDA-approved use:
Dosage Form:  Tablets: 50 mg and 100 mg
Medicine Approved By: Food and Drug Administration (FDA)
Manufacturer: US WorldMeds, LLC,
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication.  Our professional will provide you with a step-by-step guide on how to legally and safely import “safinamide tablets” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.